HRs and 95% CIs for MM development among IgG/IgA MGUS patients with thrombosis versus those without
MM transformation . | Venous thrombosis . | Arterial thrombosis . | ||||
---|---|---|---|---|---|---|
MGUS with venous thrombosis* (n = 144) . | MGUS without (n = 2580) . | HR† (95% CI) . | MGUS with arterial thrombosis‡ (n = 547) . | MGUS without (n = 2177) . | HR† (95% CI) . | |
5 years | 9 | 86 | 2.0 (0.9-4.7) | 25 | 70 | 1.4 (0.8-2.4) |
10 years | 13 | 157 | 1.2 (0.7-2.1) | 41 | 129 | 1.0 (0.7-1.5) |
MM transformation . | Venous thrombosis . | Arterial thrombosis . | ||||
---|---|---|---|---|---|---|
MGUS with venous thrombosis* (n = 144) . | MGUS without (n = 2580) . | HR† (95% CI) . | MGUS with arterial thrombosis‡ (n = 547) . | MGUS without (n = 2177) . | HR† (95% CI) . | |
5 years | 9 | 86 | 2.0 (0.9-4.7) | 25 | 70 | 1.4 (0.8-2.4) |
10 years | 13 | 157 | 1.2 (0.7-2.1) | 41 | 129 | 1.0 (0.7-1.5) |